CRT 2023

IMPELLA Utilization in High-Risk Percutaneous Coronary Intervention Mitigates the Risks of Procedural and Clinical Adverse Events Independent of Left Ventricular Ejection Fraction: The Protect III Study

Speaker(s)

• 

  Arsalan Abu-Much, MD

  Senior Cardiologist
  The Cardiovascular Research Foundation-New York
  New York, New York, United States

  Disclosure(s): No financial relationships to disclose